This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Hadasit Medical Research Services and Development Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Other. Active years: 2015-2017.
Company Filing History:

Years Active: 2015-2017
Title: Baruch Bulvik: Innovator in Immune-Related Disorder Treatments
Introduction
Baruch Bulvik is a notable inventor based in Elazar, IL. He has made significant contributions to the field of medical research, particularly in the treatment of immune-related disorders. With a total of 2 patents, his work focuses on innovative solutions that address various health challenges.
Latest Patents
Baruch Bulvik's latest patents include groundbreaking methods and compositions utilizing desferrioxamine-metal complexes. These inventions specifically involve Zinc-desferrioxamine (Zn-DFO) and gallium-desferrioxamine (Ga-DFO) complexes. The primary aim of these patents is to prevent, treat, ameliorate, or inhibit immune-related disorders. This includes skin-related inflammatory disorders such as psoriasis, inflammatory respiratory conditions like asthma, and autoimmune diseases such as diabetes.
Career Highlights
Throughout his career, Baruch has worked with esteemed organizations such as Hadasit Medical Research Services and Development Ltd. and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His experience in these institutions has allowed him to advance his research and contribute to significant medical innovations.
Collaborations
Baruch has collaborated with notable colleagues in his field, including Mordechai Chevion and Vladimir Vinokur. These partnerships have further enriched his research and development efforts.
Conclusion
Baruch Bulvik's contributions to the treatment of immune-related disorders through his innovative patents highlight his dedication to improving health outcomes. His work continues to inspire advancements in medical research and treatment methodologies.